Trial Profile
A retrospective, cohort study comparing all-cause inpatient hospitalizations in patients with dual diagnoses of schizophrenia and bipolar disorder who underwent treatment with long-acting injectable antipsychotics such as aripiprazole, haloperidol, paliperidone, and risperidone
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 25 May 2017
Price :
$35
*
At a glance
- Drugs Aripiprazole (Primary) ; Haloperidol; Paliperidone; Risperidone
- Indications Bipolar disorders; Schizophrenia
- Focus Therapeutic Use
- 24 May 2017 Results presented at the 22nd Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research
- 24 May 2017 New trial record